Production improvement of antifungal, antitrypanosomal nucleoside sinefungin by rpoB mutation and optimization of resting cell system of Streptomyces incarnatus NRRL 8089

Koji Fukuda, Takashi Tamura, Hideyuki Ito, Sayaka Yamamoto, Kozo Ochi, Kenji Inagaki

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sinefungin, a nucleoside antibiotic with potent antifungal, antiviral, and anti-trypanosome activities, has been a target for production enhancement in the past decades through medium optimization and strain improvement. For the purpose of introducing a more rational approach, we induced rpoB mutation in the producer strain, Streptomyces incarnatus NRRL 8089, by optimized UV-irradiation, and a resulting rifampicin-resistant strain rif-400 increased the sinefungin production by 7-fold. The growth and melanin production were obviously accelerated in the rifampicin-resistant high-producer mutant, while the morphological differentiation such as aerial mycelia and spiked-spore formation was retained. Molecular cloning and DNA sequencing identified a single mutation A1340G in the rpoB gene, which encodes the β-subunit of RNA polymerase, and the resulting amino acid substitution Asp447Gly corresponded to one of mutations that reportedly allowed the transcriptional up-regulation of actinorhodin production in S. coelicolor A3(2). Sinefungin production was further enhanced by resting cell system using the rpoB mutant strain in the presence of 10 mM l-Arg. d-Arg or l-ornithine did not enhance the sinefungin production, and > 50 mM urea strongly suppressed the nucleoside antibiotic production, supporting the proposed biosynthetic mechanism by which urea is liberated from the guanidino-group-bearing intermediate that is produced by enzymatic condensation of l-Arg and ATP.

Original languageEnglish
Pages (from-to)459-465
Number of pages7
JournalJournal of Bioscience and Bioengineering
Volume109
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

sinefungin
Streptomyces
Nucleosides
Mutation
Rifampin
Urea
Anti-Bacterial Agents
Antibiotics
Ornithine
Trypanosomiasis
Mycelium
Melanins
Molecular Cloning
Amino Acid Substitution
DNA-Directed RNA Polymerases
Spores
DNA Sequence Analysis
Bearings (structural)
Antiviral Agents
Melanin

Keywords

  • Rifampicin-resistance
  • rpoB gene
  • Secondary metabolism
  • Sinefungin
  • Streptomyces incarnatus

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology
  • Bioengineering

Cite this

@article{a553428e0cff4b3192cde7cfcd57a8fb,
title = "Production improvement of antifungal, antitrypanosomal nucleoside sinefungin by rpoB mutation and optimization of resting cell system of Streptomyces incarnatus NRRL 8089",
abstract = "Sinefungin, a nucleoside antibiotic with potent antifungal, antiviral, and anti-trypanosome activities, has been a target for production enhancement in the past decades through medium optimization and strain improvement. For the purpose of introducing a more rational approach, we induced rpoB mutation in the producer strain, Streptomyces incarnatus NRRL 8089, by optimized UV-irradiation, and a resulting rifampicin-resistant strain rif-400 increased the sinefungin production by 7-fold. The growth and melanin production were obviously accelerated in the rifampicin-resistant high-producer mutant, while the morphological differentiation such as aerial mycelia and spiked-spore formation was retained. Molecular cloning and DNA sequencing identified a single mutation A1340G in the rpoB gene, which encodes the β-subunit of RNA polymerase, and the resulting amino acid substitution Asp447Gly corresponded to one of mutations that reportedly allowed the transcriptional up-regulation of actinorhodin production in S. coelicolor A3(2). Sinefungin production was further enhanced by resting cell system using the rpoB mutant strain in the presence of 10 mM l-Arg. d-Arg or l-ornithine did not enhance the sinefungin production, and > 50 mM urea strongly suppressed the nucleoside antibiotic production, supporting the proposed biosynthetic mechanism by which urea is liberated from the guanidino-group-bearing intermediate that is produced by enzymatic condensation of l-Arg and ATP.",
keywords = "Rifampicin-resistance, rpoB gene, Secondary metabolism, Sinefungin, Streptomyces incarnatus",
author = "Koji Fukuda and Takashi Tamura and Hideyuki Ito and Sayaka Yamamoto and Kozo Ochi and Kenji Inagaki",
year = "2010",
month = "5",
doi = "10.1016/j.jbiosc.2009.10.017",
language = "English",
volume = "109",
pages = "459--465",
journal = "Journal of Bioscience and Bioengineering",
issn = "1389-1723",
publisher = "The Society for Biotechnology, Japan",
number = "5",

}

TY - JOUR

T1 - Production improvement of antifungal, antitrypanosomal nucleoside sinefungin by rpoB mutation and optimization of resting cell system of Streptomyces incarnatus NRRL 8089

AU - Fukuda, Koji

AU - Tamura, Takashi

AU - Ito, Hideyuki

AU - Yamamoto, Sayaka

AU - Ochi, Kozo

AU - Inagaki, Kenji

PY - 2010/5

Y1 - 2010/5

N2 - Sinefungin, a nucleoside antibiotic with potent antifungal, antiviral, and anti-trypanosome activities, has been a target for production enhancement in the past decades through medium optimization and strain improvement. For the purpose of introducing a more rational approach, we induced rpoB mutation in the producer strain, Streptomyces incarnatus NRRL 8089, by optimized UV-irradiation, and a resulting rifampicin-resistant strain rif-400 increased the sinefungin production by 7-fold. The growth and melanin production were obviously accelerated in the rifampicin-resistant high-producer mutant, while the morphological differentiation such as aerial mycelia and spiked-spore formation was retained. Molecular cloning and DNA sequencing identified a single mutation A1340G in the rpoB gene, which encodes the β-subunit of RNA polymerase, and the resulting amino acid substitution Asp447Gly corresponded to one of mutations that reportedly allowed the transcriptional up-regulation of actinorhodin production in S. coelicolor A3(2). Sinefungin production was further enhanced by resting cell system using the rpoB mutant strain in the presence of 10 mM l-Arg. d-Arg or l-ornithine did not enhance the sinefungin production, and > 50 mM urea strongly suppressed the nucleoside antibiotic production, supporting the proposed biosynthetic mechanism by which urea is liberated from the guanidino-group-bearing intermediate that is produced by enzymatic condensation of l-Arg and ATP.

AB - Sinefungin, a nucleoside antibiotic with potent antifungal, antiviral, and anti-trypanosome activities, has been a target for production enhancement in the past decades through medium optimization and strain improvement. For the purpose of introducing a more rational approach, we induced rpoB mutation in the producer strain, Streptomyces incarnatus NRRL 8089, by optimized UV-irradiation, and a resulting rifampicin-resistant strain rif-400 increased the sinefungin production by 7-fold. The growth and melanin production were obviously accelerated in the rifampicin-resistant high-producer mutant, while the morphological differentiation such as aerial mycelia and spiked-spore formation was retained. Molecular cloning and DNA sequencing identified a single mutation A1340G in the rpoB gene, which encodes the β-subunit of RNA polymerase, and the resulting amino acid substitution Asp447Gly corresponded to one of mutations that reportedly allowed the transcriptional up-regulation of actinorhodin production in S. coelicolor A3(2). Sinefungin production was further enhanced by resting cell system using the rpoB mutant strain in the presence of 10 mM l-Arg. d-Arg or l-ornithine did not enhance the sinefungin production, and > 50 mM urea strongly suppressed the nucleoside antibiotic production, supporting the proposed biosynthetic mechanism by which urea is liberated from the guanidino-group-bearing intermediate that is produced by enzymatic condensation of l-Arg and ATP.

KW - Rifampicin-resistance

KW - rpoB gene

KW - Secondary metabolism

KW - Sinefungin

KW - Streptomyces incarnatus

UR - http://www.scopus.com/inward/record.url?scp=77949893212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949893212&partnerID=8YFLogxK

U2 - 10.1016/j.jbiosc.2009.10.017

DO - 10.1016/j.jbiosc.2009.10.017

M3 - Article

VL - 109

SP - 459

EP - 465

JO - Journal of Bioscience and Bioengineering

JF - Journal of Bioscience and Bioengineering

SN - 1389-1723

IS - 5

ER -